Position in RDY
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$6,783,716
+$4,203,824 QoQ
Shares Held
489,799
+166.6% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RDY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026QUADRANT CAPITAL GROUP LLC holds $18,364,187 across 30 Drug Manufacturers - Specialty & Generic names. RDY ranks #1 (36.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RDY |
Dr Reddys Laboratories Ltd
This page
|
489,799 | $6,783,716 | |
| 2 | TAK |
Takeda Pharmaceutical Co Ltd
|
127,505 | $2,361,392 | |
| 3 | ZTS |
Zoetis Inc.
|
17,457 | $2,063,591 | |
| 4 | HLN |
Haleon plc
|
118,327 | $1,184,453 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
7,689 | $1,012,948 | |
| 6 | VTRS |
Viatris Inc
|
70,339 | $950,279 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
24,340 | $733,120 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
7,890 | $598,456 |
All Filings in RDY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,783,716 | 489,799 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,579,892 | 183,753 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,751,008 | 411,374 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,999,708 | 266,115 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,045,069 | 155,047 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,716,022 | 172,009 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,552,172 | 32,123 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,357,547 | 30,943 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,213,629 | 30,179 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,977,463 | 28,420 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,569,973 | 23,478 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,411,581 | 22,367 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,215,569 | 21,352 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $737,230 | 14,246 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $577,571 | 11,035 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $432,595 | 7,810 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $320,224 | 5,746 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $273,348 | 4,179 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $232,614 | 3,571 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $234,055 | 3,184 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $160,166 | 2,609 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $176,799 | 2,480 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $162,631 | 2,338 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $90,329 | 1,704 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $784,128 | 19,443 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||